Cytogenetic studies of germ cell tumors in prospective clinical treatment trials are warranted to define more precisely the relationship between histologic subtype, serum tumor marker production, and prognosis.
No takes yet. Share an insight, caveat, or question.
Bosl et al. (1994) studied this question.